| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.56 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |